X0508 4 2026-02-02 0 0001601485 Elicio Therapeutics, Inc. ELTX 0001612095 Haqq Christopher C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 0 1 0 0 See Remarks 0 Common Stock 2026-02-02 4 A 0 25400 0 A 57381 D Stock Option (Right to Buy) 8.10 2026-02-02 4 A 0 50900 0 A 2036-02-02 Common Stock 50900 50900 D Represents restricted stock units ("RSUs") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer. The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Executive Vice President, Head of R&D and Chief Medical Officer /s/ Christopher Haqq 2026-02-03